Responsive Therapy for Psychiatric Disorders
Abstract
A medical device is capable of delivering a form of stimulation (e.g., electrical stimulation) to a region of the cingulate cortex of the human brain to treat a neurological event, condition or disorder, especially an event, condition, or disorder that is psychiatric in nature, such as depression, bipolar disorder, anxiety and obsessive-compulsive disorders, post-traumatic stress disorder, addiction, schizophrenia, and autism and other developmental disorders. The device additionally or alternatively may be capable of detecting a biological marker or changes in a biological marker corresponding to the neurological event, condition or disorder. Methods of using the device are also disclosed.
Claims
exact text as granted — not AI-modified1 . A method for modulating the cingulate cortex of a patient's brain comprising:
implanting in the patient's body an electrode array comprising a plurality of electrodes so that the plurality of electrodes are either disposed within or against substantially the entire length of the cingulate cortex; associating the electrode array with a stimulation source; delivering stimulation from the stimulation source through at least one of the electrodes in the electrode array.
2 . The method of claim 1 , wherein delivering stimulation comprises delivering electrical stimulation.
3 . The method of claim 1 , wherein delivering stimulation comprises delivering at least one dose of a drug.
4 . The method of claim 1 , further including implanting the stimulation source in the patient's body.
5 . The method of claim 1 , further comprising triggering the delivery of stimulation with a signal corresponding to a command initiated by the patient.
6 . The method of claim 1 , wherein delivering stimulation comprises causing a temperature change at or in the vicinity of the at least one of the electrodes.
7 . The method of claim 6 , further comprising:
implanting at least one sensor in the patient's body; detecting at least one biological marker with the at least one sensor.
8 . The method of claim 7 , wherein the biological marker is a biological marker from the group consisting of electrical activity, concentration of inhibitory or excitatory neurochemicals, concentration of proteins or other gene products, temperature, and metabolic rate.
9 . The method of claim 7 , wherein detecting the at least one biological marker further comprises monitoring the at least one biological marker over a predetermined period of time.
10 . The method of claim 9 , wherein delivering stimulation further comprises delivering stimulation based on predefined changes in the detected and monitored at least one biological marker.
11 . The method of claim 9 , wherein monitoring the at least one biological marker over a predetermined period of time further includes continuously monitoring the at least one biological marker.
12 . A device for modulating the function of the cingulate cortex of a patient's brain comprising:
an electrode array comprising a plurality of electrodes designed for and intended to be deployed so that the electrodes can be used to deliver stimulation to substantially any area of the cingulate cortex; a stimulation source associated with the electrode array for delivering a form of stimulation through at least one of the electrodes in the electrode array; a programmable selector circuit for selecting one or more of the electrodes in the electrode array through which stimulation can be delivered.
13 . The device of claim 13 , further including at least one sensor for detecting at least one biological marker from the patient.
14 . The device of claim 14 , further including a monitoring circuit for monitoring information sensed by the at least one sensor for a programmable period of time.
15 . The device of claim 13 , wherein the stimulation source is a signal generator for generating electrical stimulation.
16 . The device of claim 13 , wherein the biological marker is a biological marker from the group consisting of electrical activity, concentration of inhibitory or excitatory neurochemicals, concentration of proteins or other gene products, temperature, and metabolic rate.Join the waitlist — get patent alerts
Track US2008125831A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.